Vergoeding 2016-2020 voor ATC-subgroep M03BX : Overige centraal werkende middelen
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| M03BX01 Baclofen (Lioresal ®) | 1.736.500 | 1.770.400 | 1.831.000 | 1.893.300 | 1.911.600 |
| M03BX02 Tizanidine (Sirdalud ®) | 364.560 | 311.930 | 289.080 | 294.630 | 317.480 |
| M03BX04 Tolperison (Tolpermyo ®) | 9.745 | 119.870 | 231.890 | 276.910 | 328.510 |
| Totaal | 2.110.805 | 2.202.200 | 2.351.970 | 2.464.840 | 2.557.590 |